| Integrated genomic analyses of ovarian carcinoma Cancer Genome Atlas Research Network Nature 474 (7353), 609, 2011 | 6891 | 2011 |
| Integrated genomic characterization of endometrial carcinoma DA Levine, ... Nature 497 (7447), 67-73, 2013 | 4900 | 2013 |
| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4482 | 2018 |
| Incorporation of bevacizumab in the primary treatment of ovarian cancer RA Burger, MF Brady, MA Bookman, GF Fleming, BJ Monk, H Huang, ... New England Journal of Medicine 365 (26), 2473-2483, 2011 | 2801 | 2011 |
| An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018 | 2647 | 2018 |
| Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 2496 | 2018 |
| Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis M Verheij, R Bose, X Hua Lin, B Yao, WD Jarvis, S Grant, MJ Birrer, ... Nature 380 (6569), 75-79, 1996 | 2266 | 1996 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2193 | 2018 |
| Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018 | 2048 | 2018 |
| Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial RL Coleman, AM Oza, D Lorusso, C Aghajanian, A Oaknin, A Dean, ... The Lancet 390 (10106), 1949-1961, 2017 | 1619 | 2017 |
| Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018 | 1611 | 2018 |
| p53: a frequent target for genetic abnormalities in lung cancer T Takahashi, MM Nau, I Chiba, MJ Birrer, RK Rosenberg, M Vinocour, ... Science 246 (4929), 491-494, 1989 | 1591 | 1989 |
| BRCA mutation frequency and patterns of treatment response in BRCA mutation–positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group K Alsop, S Fereday, C Meldrum, A DeFazio, C Emmanuel, J George, ... Journal of clinical oncology 30 (21), 2654, 2012 | 1405 | 2012 |
| Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ... Nature reviews Cancer 15 (11), 668-679, 2015 | 1161 | 2015 |
| Integrated genomic and molecular characterization of cervical cancer Cancer Genome Atlas Research Network Nature 543 (7645), 378, 2017 | 1010 | 2017 |
| Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73 T Smeal, B Binetruy, DA Mercola, M Birrer, M Karin Nature 354 (6353), 494-496, 1991 | 1005 | 1991 |
| Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ... Cell reports 23 (1), 239-254. e6, 2018 | 924 | 2018 |
| Dicer, Drosha, and outcomes in patients with ovarian cancer WM Merritt, YG Lin, LY Han, AA Kamat, WA Spannuth, R Schmandt, ... New England Journal of Medicine 359 (25), 2641-2650, 2008 | 894 | 2008 |
| Genomic and functional approaches to understanding cancer aneuploidy AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ... Cancer cell 33 (4), 676-689. e3, 2018 | 880 | 2018 |
| Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images J Saltz, R Gupta, L Hou, T Kurc, P Singh, V Nguyen, D Samaras, ... Cell reports 23 (1), 181-193. e7, 2018 | 841 | 2018 |
